These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30268340)

  • 21. Clozapine withdrawal malignant catatonia in a medical intensive care unit setting.
    Brailey J; Bastiampillai T
    Asian J Psychiatr; 2020 Aug; 52():102043. PubMed ID: 32311586
    [No Abstract]   [Full Text] [Related]  

  • 22. Catatonia and mania in patient with AIDS: treatment with lorazepam and risperidone.
    Prakash O; Bagepally BS
    Gen Hosp Psychiatry; 2012; 34(3):321.e5-6. PubMed ID: 22361355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clozapine withdrawal catatonia in a young schizophrenic man.
    Lucchelli JP; Kourakou S; Hasler G; Hilal R
    Encephale; 2021 Aug; 47(4):396-398. PubMed ID: 33293035
    [No Abstract]   [Full Text] [Related]  

  • 24. Relapses and recurrences of catatonia: 30-case analysis and literature review.
    Lin CC; Hung YY; Tsai MC; Huang TL
    Compr Psychiatry; 2016 Apr; 66():157-65. PubMed ID: 26995249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Organic catatonia following frontal lobe injury: response to clozapine.
    Rommel O; Tegenthoff M; Widdig W; Bräunig P; Malin JP
    J Neuropsychiatry Clin Neurosci; 1998; 10(2):237-8. PubMed ID: 9608419
    [No Abstract]   [Full Text] [Related]  

  • 26. Amisulpride Augmentation in Acute Catatonia.
    Arora M; Banal R; Praharaj SK; Mahajan V
    Am J Ther; 2017; 24(4):e381-e385. PubMed ID: 26270797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seizures after discontinuation of low-dose lorazepam from originally seizure-free clozapine regimen: combined effects?
    Lane HY; Su KP; Chang WH
    J Clin Psychiatry; 1999 Jun; 60(6):408-9. PubMed ID: 10401922
    [No Abstract]   [Full Text] [Related]  

  • 28. Catatonia in a child with autistic disorder.
    Bozkurt H; Mukaddes NM
    Turk J Pediatr; 2010; 52(4):435-8. PubMed ID: 21043395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic catatonia with obsessive compulsive disorder symptoms treated with lorazepam, memantine, aripiprazole, fluvoxamine and neurosurgery.
    Mukai Y; Two A; Jean-Baptiste M
    BMJ Case Rep; 2011 Aug; 2011():. PubMed ID: 22687661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparing the effect of clozapine and risperidone on cue reactivity in male patients with schizophrenia and a cannabis use disorder: A randomized fMRI study.
    Machielsen MWJ; Veltman DJ; van den Brink W; de Haan L
    Schizophr Res; 2018 Apr; 194():32-38. PubMed ID: 28351544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of the GABAergic system in catatonia-Insights from clozapine and benzodiazepines.
    Plevin D; Mohan T; Bastiampillai T
    Asian J Psychiatr; 2018 Feb; 32():145-146. PubMed ID: 29272785
    [No Abstract]   [Full Text] [Related]  

  • 32. Clozapine withdrawal catatonia and neuroleptic malignant syndrome: a case report.
    Lee JW; Robertson S
    Ann Clin Psychiatry; 1997 Sep; 9(3):165-9. PubMed ID: 9339882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catatonia and cannabis withdrawal: A case report.
    Caudron M; Rolland B; Deheul S; Geoffroy PA; Thomas P; Amad A
    Subst Abus; 2016; 37(1):188-9. PubMed ID: 26247767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immobility in patients with advanced dementia may actually be a form of a Lorazepam-reversible catatonia].
    Alisky JM
    Rev Med Chil; 2008 Oct; 136(10):1359-60. PubMed ID: 19194638
    [No Abstract]   [Full Text] [Related]  

  • 35. Clozapine Withdrawal-Induced Malignant Catatonia or Neuroleptic Malignant Syndrome: A Case Report and a Brief Review of the Literature.
    Belteczki Z; Ujvari J; Dome P
    Clin Neuropharmacol; 2021 Jul-Aug 01; 44(4):148-153. PubMed ID: 34132673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergism of lorazepam and electroconvulsive therapy in the treatment of catatonia.
    Petrides G; Divadeenam KM; Bush G; Francis A
    Biol Psychiatry; 1997 Sep; 42(5):375-81. PubMed ID: 9276078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monocyte abnormality in catatonia: revisiting the immune theory of catatonia.
    Rao NP; Mutalik NR; Kasal V; Venkatasubramanian G; Behere RV; Varambally S; Gangadhar BN
    J ECT; 2011 Sep; 27(3):e53-4. PubMed ID: 21865953
    [No Abstract]   [Full Text] [Related]  

  • 38. Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine.
    Paparrigopoulos T; Tzavellas E; Ferentinos P; Mourikis I; Liappas J
    World J Biol Psychiatry; 2009; 10(1):70-3. PubMed ID: 19673089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe withdrawal akathisia following neuroleptic discontinuation successfully controlled by clozapine.
    Poyurovsky M; Hermesh H; Weizman A
    Int Clin Psychopharmacol; 1996 Dec; 11(4):283-6. PubMed ID: 9031996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pregnancy and malignant catatonia.
    Espínola-Nadurille M; Ramírez-Bermúdez J; Fricchione GL
    Gen Hosp Psychiatry; 2007; 29(1):69-71. PubMed ID: 17189750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.